TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ELUSYS THERAPEUTICS INC

ImmunologyDermatology
Biotech

ELUSYS THERAPEUTICS INC is a biotechnology company focused on Immunology, Dermatology. Key products include ANTHIM.

2016
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

ANTHIM
obiltoxaximab
PA 1 indications · 2016

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 93%
0 drugs Phase 3: 5 Phase 2: 3
Dermatology 7%
0 drugs Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Dermatology, Immunology
Eli Lilly big-pharma
Immunology, Dermatology
BAUSCH specialty
Dermatology, Immunology
COSETTE other
Dermatology, Immunology
BAUSCH AND LOMB specialty
Dermatology, Immunology